Literature DB >> 17404836

Species differences in the selective inhibition of monoamine oxidase (1-methyl-2-phenylethyl)hydrazine and its potentiation by cyanide.

Zakia Ben Ramadan1, Maria L Wrang, Keith F Tipton.   

Abstract

The potentiating effects of cyanide on the inhibition of rat liver mitochondrial monoamine oxidase-A & B and of ox liver mitochondrial MAO-B by pheniprazine [(1-methyl-2-phenylethyl)hydrazine] has been studied. Pheniprazine was shown to behave as a mechanism-based MAO inhibitor. For rat liver MAO-B, the initial non-covalent step was characterized by dissociation constant (K (i)) of 2450 nM and the first-order rate constant (k (+2)) for the covalent adduct formation was 0.16 min(-1). As a reversible inhibitor it was selective towards rat liver MAO-A (K (i) = 420 nM) but the rate of irreversible inhibition of that enzyme was considerably slower (k (+2) = 0.06 min(-1)). MAO-B from ox liver more closely resembled MAO-A from the rat in sensitivity to reversible inhibition by pheniprazine (K (i) = 450 nm) but it was closer to rat liver MAO-B in rate of irreversible inhibition (k (+2) = 0.29 min(-1)). The K (i) values were significantly decreased in the presence of KCN but there was little effect on the k (+2) values. However, sensitivities of the different enzymes to KCN varied widely and considerably higher concentrations of KCN were required for this effect to be apparent with the rat liver mitochondrial MAO-A than with MAO-B from rat and ox liver. The kinetic behaviour of cyanide activation was consistent with partial (non-essential) competitive activation in all cases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404836     DOI: 10.1007/s11064-007-9309-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

1.  Some peculiar aspects of monoamine oxidase inhibition.

Authors:  Z B Ramadan; P Dostert; K F Tipton
Journal:  Neurobiology (Bp)       Date:  1999

2.  Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors.

Authors:  Frantisek Hubálek; Claudia Binda; Ashraf Khalil; Min Li; Andrea Mattevi; Neal Castagnoli; Dale E Edmondson
Journal:  J Biol Chem       Date:  2005-02-14       Impact factor: 5.157

3.  Establishing the kinetic competency of the cationic imine intermediate in nitroalkane oxidase.

Authors:  Michael P Valley; Shane E Tichy; Paul F Fitzpatrick
Journal:  J Am Chem Soc       Date:  2005-02-23       Impact factor: 15.419

4.  Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B.

Authors:  A A Reid; J L Hill; D L Murphy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

5.  The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidase.

Authors:  M D Houslay; K F Tipton
Journal:  Biochem J       Date:  1973-09       Impact factor: 3.857

6.  Monoamine oxidase from beef liver mitochondria: simplified isolation procedure, properties, and determination of its cysteinyl flavin content.

Authors:  J I Salach
Journal:  Arch Biochem Biophys       Date:  1979-01       Impact factor: 4.013

7.  Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.

Authors:  E M O'Brien; P Dostert; K F Tipton
Journal:  Biochem Pharmacol       Date:  1995-07-31       Impact factor: 5.858

8.  The kinetics of phenethylhydrazine oxidation by monoamine oxidase.

Authors:  K F Tipton; I P Spires
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

9.  Structural comparison of human monoamine oxidases A and B: mass spectrometry monitoring of cysteine reactivities.

Authors:  Frantisek Hubalek; Jan Pohl; Dale E Edmondson
Journal:  J Biol Chem       Date:  2003-05-29       Impact factor: 5.157

10.  The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.

Authors:  C J Fowler; T J Mantle; K F Tipton
Journal:  Biochem Pharmacol       Date:  1982-11-15       Impact factor: 5.858

View more
  3 in total

Review 1.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

Review 2.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

Review 3.  Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease.

Authors:  Mercedes Unzeta; Gerard Esteban; Irene Bolea; Wieslawa A Fogel; Rona R Ramsay; Moussa B H Youdim; Keith F Tipton; José Marco-Contelles
Journal:  Front Neurosci       Date:  2016-05-25       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.